EKF Diagnostics: looking good, but what next?
Much like every business touching the Covid-19 testing space, shares in EKF Diagnostic (LON:EKF), the global medical manufacturer of point-of-care and central lab devices and chemistry reagents, have had an excellent run over recent months.
The latest trading update confirmed that that full year performance remains in-line with management expectations, which have already been revised upwards several times this year.
While their PrimeStore MTM COVID-19 sample collection device has been…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Arcontech Group
27/10/2023 · Company Insights
Several companies covered here have growing cash piles – for one cash represents more than half…
01/09/2021 · Company Insights
Two companies covered here supporting the hospitality sector have experienced contrasting fortunes over the year, with…
More on EKF Diagnostics Holdings
12/01/2021 · Company Insights
There are a broad range of trading updates covered here, but we can’t understand why one company bothered, when…
09/11/2020 · Company Insights
Two pioneering companies supporting the renewable energy arena announced positive developments for their rapidly developing technologies.
More Company Insights
Online wine retail is a tough gig
Trading update and a first acquisition expands the market opportunity
Our Bonkers Bargain is the pick of the bunch
More on Arcontech Group
More on EKF Diagnostics Holdings
More Company Insights